INT353009

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.00
First Reported 2007
Last Reported 2007
Negated 1
Speculated 0
Reported most in Body
Documents 1
Total Number 1
Disease Relevance 0
Pain Relevance 0.29

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transport (GJA8) plasma membrane (GJA8)
GJA8 (Homo sapiens)
VSIG1 (Homo sapiens)
Pain Link Frequency Relevance Heat
Etanercept 6 95.08 Very High Very High Very High
Adalimumab 33 94.44 High High
Infliximab 65 93.96 High High
Potency 1 56.88 Quite High
Bioavailability 2 41.76 Quite Low
cytokine 4 33.76 Quite Low
corticosteroid 16 5.00 Very Low Very Low Very Low
Inflammation 13 5.00 Very Low Very Low Very Low
methotrexate 5 5.00 Very Low Very Low Very Low
abdominal pain 4 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disease 98 8.16 Low Low
Inflammatory Bowel Disease 12 5.00 Very Low Very Low Very Low
INFLAMMATION 11 5.00 Very Low Very Low Very Low
Apoptosis 11 5.00 Very Low Very Low Very Low
Urinary Tract Infection 4 5.00 Very Low Very Low Very Low
Abdominal Pain 4 5.00 Very Low Very Low Very Low
Vomiting 4 5.00 Very Low Very Low Very Low
Abscess 4 5.00 Very Low Very Low Very Low
Infection 4 5.00 Very Low Very Low Very Low
Recurrence 4 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Since it lacks the Fc portion of the antibody, CZP only exerts its activity through binding to soluble and membrane-bound TNF-alfa, and cannot bind to cell-surface receptors for antibodies; consequently, complement fixation and cell lysis do not occur.
CZP Neg (cannot) Binding (bind) of cell-surface
1) Confidence 0.00 Published 2007 Journal Core Evidence Section Body Doc Link PMC3012434 Disease Relevance 0 Pain Relevance 0.29

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox